Piiha Lotta Jerevall

Summary

Country: Sweden

Publications

  1. ncbi Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome
    Piiha Lotta Jerevall
    Department of Biomedicine and Surgery, Division of Oncology, Linkoping University, Linkoping, Sweden
    Breast Cancer Res Treat 107:225-34. 2008
  2. pmc Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer
    Piiha Lotta Jerevall
    Department of Clinical and Experimental Medicine, Division of Oncology, Faculty of Health Sciences, Linkoping University, SE 58185 Linkoping, Sweden
    Breast Cancer Res 12:R53. 2010
  3. ncbi Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer
    Cecilia Gunnarsson
    Department of Pathology Cytology and Genetics, Division of Genetics, Linkoping University Hospital, Linkoping, Sweden
    Breast Cancer Res Treat 108:35-41. 2008
  4. ncbi Sulfotransferase1A1 and risk of postmenopausal breast cancer
    Piiha Lotta Jerevall
    Department of Biomedicine and Surgery, Division of Cellbiology, Faculty of Health Sciences, University Hospital, S 581 85 Linkoping, Sweden
    Anticancer Res 25:2515-7. 2005
  5. doi Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence
    Yi Zhang
    bioTheranostics, Inc, San Diego, California, USA
    Clin Cancer Res 19:4196-205. 2013

Detail Information

Publications5

  1. ncbi Exploring the two-gene ratio in breast cancer--independent roles for HOXB13 and IL17BR in prediction of clinical outcome
    Piiha Lotta Jerevall
    Department of Biomedicine and Surgery, Division of Oncology, Linkoping University, Linkoping, Sweden
    Breast Cancer Res Treat 107:225-34. 2008
    ..Based on the current knowledge of HOXB13 and IL17BR, we hypothesized that these genes may have individual prognostic or predictive power...
  2. pmc Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer
    Piiha Lotta Jerevall
    Department of Clinical and Experimental Medicine, Division of Oncology, Faculty of Health Sciences, Linkoping University, SE 58185 Linkoping, Sweden
    Breast Cancer Res 12:R53. 2010
    ..No studies have been made regarding the HOXB13 protein levels in breast cancer. The aim of our study was to investigate whether tamoxifen benefit can be correlated to different levels of HOXB13 protein expression...
  3. ncbi Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer
    Cecilia Gunnarsson
    Department of Pathology Cytology and Genetics, Division of Genetics, Linkoping University Hospital, Linkoping, Sweden
    Breast Cancer Res Treat 108:35-41. 2008
    ..Furthermore, we found that amplification of the gene had prognostic significance in multivariate analysis adjusting for other clinicopathological variables...
  4. ncbi Sulfotransferase1A1 and risk of postmenopausal breast cancer
    Piiha Lotta Jerevall
    Department of Biomedicine and Surgery, Division of Cellbiology, Faculty of Health Sciences, University Hospital, S 581 85 Linkoping, Sweden
    Anticancer Res 25:2515-7. 2005
    ..e. neither of the alleles is associated with an increased risk of breast cancer in the present study...
  5. doi Breast cancer index identifies early-stage estrogen receptor-positive breast cancer patients at risk for early- and late-distant recurrence
    Yi Zhang
    bioTheranostics, Inc, San Diego, California, USA
    Clin Cancer Res 19:4196-205. 2013
    ..Residual risk of relapse remains a substantial concern for patients with hormone receptor-positive breast cancer, with approximately half of all disease recurrences occurring after five years of adjuvant antiestrogen therapy...